Latest News and Press Releases

Embecta Investors may have been Misled after Insulin Pen Issues Lead to 57% Stock Drop – Contact BFA Law if You Lost Money

Embecta Misrepresentations about Insulin Pen Issues Under Review in Securities Fraud Class Action – Contact BFA Law if You Lost Money

Shareholders of Embecta Corp. (NSADAQ: EMBC); Erasca, Inc. (NASDAQ: ERAS); Hub Group, Inc. (NASDAQ: HUBG); and ZoomInfo Technologies, Inc. (NASDAQ: GTM):

Embecta (NASDAQ:EMBC) Insulin Pen Issues Trigger Securities Fraud Class Action – Investors Notified to Contact BFA Law about the Lawsuit

Embecta Investors that Lost Money after Insulin Pen Issues Disclosed are Notified to Contact BFA Law about the Filed Securities Fraud Class Action

Embecta Sued for Securities Fraud After Insulin Pen Issues Spark a 57% Stock Drop – Investors Notified to Contact BFA Law by August 17

Embecta Accused of Making Misrepresentations about its Insulin Pen Issues in Securities Fraud Class Action – Investors Notified to Contact BFA Law

Embecta Investors Bring Securities Class Action Following Insulin Pen Issues – Contact BFA Law by August 17 Deadline

Embecta Investors are Notified to Contact BFA Law about the Pending Securities Fraud Class Action to Recover Stock Losses

Embecta Investors Sue for Recovery in Securities Fraud Class Action after 57% Stock Drop – Investors Notified to Contact BFA Law